Page 24 of 52
Previous Page     Next Page        Smaller fonts | Larger fonts     Go back to the flash version
EU_Neuro_foreword.qxp 19/7/07 09:43 Page 22
Stroke An Introduction
an introduction by
Arne Hagen
President, Stroke Alliance for Europe
Arne Hagen has been President of Stroke Alliance for Europe since its establishment in 2004. He is also a board member of the European
Federation of Neurological Associations and President of the Norwegian Association for Stroke Survivors. Prior to his stroke in August
1997, he was a Colonel in the Royal Norwegian Air Force. His service in the air force included Aide de Camp for HM King Olav,
Commanding Officer at Bardufoss Air Force Station, Chief of the Foreign Liaison Office, Norway and Branch Chief of the NATO
headquarters in High Wycombe, UK.
A
s President of Stroke Alliance for Europe, my focus is naturally on stroke. According to the World Health
Organization, stroke kills more than 5 million people a year worldwide and disables an additional 5–6 million people
a year. Research into acute stroke treatment and rehabilitation is progressing, but there is still a long way to go before we
meet the 2006 Helsingborg declaration on stroke. In this declaration, the goals for 2015 are as follows:
Organisation of Stroke Services
• All patients in Europe with stroke will have access to a continuum of care, from organised stroke units in the acute phase
to appropriate rehabilitation and secondary prevention measures.
Management of Acute Stroke
• More than 85% of stroke patients should survive the first month after stroke.
• More than 70% of survivors should be independent in their activities of daily living at three months after the onset of stroke.
• All patients with acute stroke who are potentially eligible for acute specific treatment should be transferred to hospitals
with the technical capabilities and expertise to administer such treatments.
Prevention
• The mortality of stroke should be reduced by at least 20% from the 2005 level.
• All countries should aim at reducing major determinants of stroke in their populations, most importantly hypertension
and smoking.
• All patients who have suffered a transient ischaemic attack or stroke should receive appropriate secondary
preventative measures.
Evaluation of Stroke Outcome and Quality Assessment
• All EU Member States should establish a system for routine collection of the data needed to evaluate the quality of stroke
management, including patient safety issues.
If we are to meet these goals, health policy makers and researchers must start working towards them today. ■
22 © TOUCH BRIEFINGS 2007
Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     Go back to the flash version
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52